Earlier, AstraZeneca said it had been cleared by the FDA to restart a trial that had been halted in the U.S. after a volunteer participating in a U.K. trial of the shot had fallen ill
from Home Page https://ift.tt/3mlzu2F
from Home Page https://ift.tt/3mlzu2F
Comments
Post a Comment